KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Amgen (AMGN) Receivables - Other (2018 - 2024)

Amgen has reported Receivables - Other over the past 8 years, most recently at $198.0 million for Q4 2024.

  • For Q4 2024, Receivables - Other fell 60.56% year-over-year to $198.0 million; the TTM value through Dec 2024 reached $198.0 million, down 60.56%, while the annual FY2024 figure was $198.0 million, 60.56% down from the prior year.
  • Receivables - Other for Q4 2024 was $198.0 million at Amgen, down from $502.0 million in the prior quarter.
  • Over five years, Receivables - Other peaked at $583.0 million in Q4 2020 and troughed at $61.0 million in Q4 2021.
  • A 5-year average of $294.6 million and a median of $198.0 million in 2024 define the central range for Receivables - Other.
  • Biggest five-year swings in Receivables - Other: tumbled 89.54% in 2021 and later skyrocketed 289.15% in 2023.
  • Year by year, Receivables - Other stood at $583.0 million in 2020, then tumbled by 89.54% to $61.0 million in 2021, then surged by 111.48% to $129.0 million in 2022, then skyrocketed by 289.15% to $502.0 million in 2023, then crashed by 60.56% to $198.0 million in 2024.
  • Business Quant data shows Receivables - Other for AMGN at $198.0 million in Q4 2024, $502.0 million in Q4 2023, and $129.0 million in Q4 2022.